BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33882259)

  • 21. Holding All the Cards-How Fanconi Anemia Proteins Deal with Replication Stress and Preserve Genomic Stability.
    Datta A; Brosh RM
    Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30813363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
    Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
    Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Snm1B/Apollo functions in the Fanconi anemia pathway in response to DNA interstrand crosslinks.
    Mason JM; Sekiguchi JM
    Hum Mol Genet; 2011 Jul; 20(13):2549-59. PubMed ID: 21478198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FANCD2 binds CtIP and regulates DNA-end resection during DNA interstrand crosslink repair.
    Unno J; Itaya A; Taoka M; Sato K; Tomida J; Sakai W; Sugasawa K; Ishiai M; Ikura T; Isobe T; Kurumizaka H; Takata M
    Cell Rep; 2014 May; 7(4):1039-47. PubMed ID: 24794430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples.
    Spanswick VJ; Lowe HL; Newton C; Bingham JP; Bagnobianchi A; Kiakos K; Craddock C; Ledermann JA; Hochhauser D; Hartley JA
    BMC Cancer; 2012 Sep; 12():436. PubMed ID: 23020514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-link structure affects replication-independent DNA interstrand cross-link repair in mammalian cells.
    Hlavin EM; Smeaton MB; Noronha AM; Wilds CJ; Miller PS
    Biochemistry; 2010 May; 49(18):3977-88. PubMed ID: 20373772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unhooking of an interstrand cross-link at DNA fork structures by the DNA glycosylase NEIL3.
    Imani Nejad M; Housh K; Rodriguez AA; Haldar T; Kathe S; Wallace SS; Eichman BF; Gates KS
    DNA Repair (Amst); 2020 Feb; 86():102752. PubMed ID: 31923807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Fanconi anemia pathway and DNA interstrand cross-link repair.
    Su X; Huang J
    Protein Cell; 2011 Sep; 2(9):704-11. PubMed ID: 21948210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tip60 is required for DNA interstrand cross-link repair in the Fanconi anemia pathway.
    Hejna J; Holtorf M; Hines J; Mathewson L; Hemphill A; Al-Dhalimy M; Olson SB; Moses RE
    J Biol Chem; 2008 Apr; 283(15):9844-51. PubMed ID: 18263878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Fanconi anemia pathway and ICL repair: implications for cancer therapy.
    Wang LC; Gautier J
    Crit Rev Biochem Mol Biol; 2010 Oct; 45(5):424-39. PubMed ID: 20807115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. XPF-ERCC1 acts in Unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4.
    Klein Douwel D; Boonen RA; Long DT; Szypowska AA; Räschle M; Walter JC; Knipscheer P
    Mol Cell; 2014 May; 54(3):460-71. PubMed ID: 24726325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel role for Fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells.
    Song IY; Barkley LR; Day TA; Weiss RS; Vaziri C
    Cell Cycle; 2010 Jun; 9(12):2375-88. PubMed ID: 20519958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy.
    Jo U; Kim H
    Mol Cells; 2015 Aug; 38(8):669-76. PubMed ID: 26194820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing over-resection by DNA2 helicase/nuclease suppresses repair defects in Fanconi anemia cells.
    Karanja KK; Lee EH; Hendrickson EA; Campbell JL
    Cell Cycle; 2014; 13(10):1540-50. PubMed ID: 24626199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Boolean network model of the FA/BRCA pathway.
    Rodríguez A; Sosa D; Torres L; Molina B; Frías S; Mendoza L
    Bioinformatics; 2012 Mar; 28(6):858-66. PubMed ID: 22267503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective FANCI binding by a fanconi anemia-related FANCD2 mutant.
    Sato K; Ishiai M; Takata M; Kurumizaka H
    PLoS One; 2014; 9(12):e114752. PubMed ID: 25489943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ubiquitylation and the Fanconi anemia pathway.
    Garner E; Smogorzewska A
    FEBS Lett; 2011 Sep; 585(18):2853-60. PubMed ID: 21605559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distortion-dependent unhooking of interstrand cross-links in mammalian cell extracts.
    Smeaton MB; Hlavin EM; McGregor Mason T; Noronha AM; Wilds CJ; Miller PS
    Biochemistry; 2008 Sep; 47(37):9920-30. PubMed ID: 18702509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway.
    Yamamoto KN; Kobayashi S; Tsuda M; Kurumizaka H; Takata M; Kono K; Jiricny J; Takeda S; Hirota K
    Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6492-6. PubMed ID: 21464321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orchestrating the nucleases involved in DNA interstrand cross-link (ICL) repair.
    Sengerová B; Wang AT; McHugh PJ
    Cell Cycle; 2011 Dec; 10(23):3999-4008. PubMed ID: 22101340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.